During the past decade, Clinica Universitaria Colombia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Universitaria Colombia" #1 sponsor was "Merck Sharp & Dohme LLC" with 2 trials, followed by "Aragon Pharmaceuticals, Inc." with 1 trials sponsored, "Bayer" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Universitaria Colombia" #1 collaborator was "Clínica Colsanitas-Clínica Universitaria Colombia" with 1 trials as a collaborator, "Clínica Infantil Santa María del Lago" with 1 trials as a collaborator, "Fundación Cardioinfantil Instituto de Cardiología" with 1 trials as a collaborator, "Hospital Universitario Nacional de Colombia (HUN)" with 1 trials as a collaborator and "Hospital Universitario San Ignacio" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Universitaria Colombia" are "Prostatic Neoplasms" (3 trials), "COVID-19" (1 trials), "Caloric Deficit" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Colonoscopy" (1 trials). Many other conditions were trialed in "Clinica Universitaria Colombia" in a lesser frequency.

Most popular intervention types in "Clinica Universitaria Colombia" are "Drug" (8 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pembrolizumab" (3 trials), "Docetaxel" (2 trials), "ADT (Standard of Care)" (1 trials) and "Apalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Universitaria Colombia" are 6 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinica Universitaria Colombia". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinica Universitaria Colombia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Universitaria Colombia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".